Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share - Narrative (Details)

v3.25.3
Net Loss Per Share - Narrative (Details) - $ / shares
Sep. 30, 2025
Dec. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock, shares outstanding (in shares) 22,124,733 8,656,122
U.S. Bounti Warrant    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock, shares outstanding (in shares) 550,000  
Warrant price (in dollars per share) $ 0.125